178
Participants
Start Date
March 31, 2012
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2016
Aspirin (80 mg/d) + clopidogrel (75 mg/d)
Aspirin (80 mg/d) + clopidogrel (75 mg/d) Aspirin therapy will start at least 24 hrs before the TAVI procedure and continued for at least 6 months. Clopidogrel therapy will start within 24 hrs before the TAVI procedure in cases where a transfemoral approach is used and within 24 hrs after the TAVI procedure in cases where a transapical approach is used. The initial dose of clopidogrel will be of 300 mg followed by 75 mg/die. The duration of clopidogrel treatment will be of 3 months. Patients will be followed either by phone contact or clinical visits at 1- and 12-month follow-up.
Aspirin
Aspirin (80 mg/d) Aspirin therapy will start at least 24 hrs before the TAVI procedure and continued for at least 6 months.
St-Paul's Hospital, Vancouver
IUCPQ, Québec
Collaborators (1)
Edwards Lifesciences
INDUSTRY
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
OTHER